|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.080 CNY | +0.99% |
|
-5.40% | -31.07% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.22B 771M 674M 623M 585M 1.09B 72.72B 1.1B 7.4B 2.86B 35.83B 2.89B 2.83B 124B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.08B 602M 527M 487M 457M 853M 56.82B 859M 5.78B 2.24B 28B 2.26B 2.21B 97.15B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.41% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +0.99% | ||
| 1 week | -5.40% | ||
| Current month | -13.61% | ||
| 1 month | -18.46% | ||
| 3 months | -12.86% | ||
| 6 months | -35.45% | ||
| Current year | -31.07% |
| 1 week | 4.95 |  | 5.46 |
| 1 month | 4.95 | | 6.16 |
| Current year | 4.95 | | 9.4 |
| 1 year | 4.95 | | 9.4 |
| 3 years | 4.95 | | 16.09 |
| 5 years | 4.95 | | 16.09 |
| 10 years | 4.95 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 23/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 10/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-04 | Buy | Director | 100 | 0.0000% | ||
| 28/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 27/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | -5.40% | -27.94% | -49.05% | 771M | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.17% | -3.25% | +15.31% | +31.12% | 330.31B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.48% | +63.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.58M 85.29M 78.85M 74.05M 138M 9.2B 139M 936M 362M 4.53B 366M 358M 15.74B | 624M 92.14M 80.54M 74.46M 69.93M 130M 8.69B 131M 884M 342M 4.28B 346M 338M 14.86B |
| Net income | -74.07M -10.94M -9.57M -8.84M -8.3M -15.49M -1.03B -15.6M -105M -40.63M -509M -41.07M -40.19M -1.76B | -347M -51.3M -44.84M -41.45M -38.93M -72.61M -4.84B -73.14M -492M -190M -2.38B -193M -188M -8.27B |
| Net Debt | -1.98B -293M -256M -237M -222M -415M -27.62B -418M -2.81B -1.09B -13.61B -1.1B -1.08B -47.23B | -1.14B -169M -147M -136M -128M -239M -15.9B -240M -1.62B -626M -7.84B -633M -619M -27.19B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 5.080 ¥ | +0.99% | 19,168,410 |
| 17/06/26 | 5.030 ¥ | -2.71% | 20,344,360 |
| 16/06/26 | 5.170 ¥ | -2.64% | 22,337,080 |
| 15/06/26 | 5.310 ¥ | -1.12% | 21,922,660 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
